Local gene transduction of cyclooxygenase-1 increases blood flow in injured atherosclerotic rabbit arteries

Circulation

Volumn 111, Issue 14, 2005, Pages 1833-1840

  Liu, Qi ^a   Chen, Zhi Qiang ^a,b   Bobustuc, George C ^a   McNatt, Janice M ^b   Segall, Harry ^a   Pan, Su ^a   Willerson, James T ^a,b   Zoldhelyi, Pierre ^a,b,c  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c TEXAS HEART INSTITUTE   (United States)

Author keywords

Angioplasty; Blood flow; Gene therapy; Prostaglandins; Thrombus

Indexed keywords

ADENOVIRUS VECTOR; ARACHIDONIC ACID; CYCLIC AMP; CYCLOOXYGENASE 1; PROSTACYCLIN; PROSTAGLANDIN E1; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW; BLOOD FLOW VELOCITY; CAROTID ARTERY INJURY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPPLER FLOWMETRY; EXPERIMENTAL MODEL; FEMALE; GENETIC TRANSDUCTION; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; MALE; NONHUMAN; NULL ALLELE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RABBIT; RESTENOSIS; VASODILATATION; VIRAL GENE THERAPY;

ANGIOPLASTY, BALLOON; ANIMALS; ARTERIOSCLEROSIS; CAROTID ARTERY INJURIES; CAROTID STENOSIS; CYCLIC AMP; CYCLOOXYGENASE 1; GENE THERAPY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RABBITS; REGIONAL BLOOD FLOW; TRANSDUCTION, GENETIC; UP-REGULATION;

EID: 17144380441     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000158480.28733.89     Document Type: Article

References (49)

1. Lefkovits J, Topol EJ. Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention. Prog Cardiovasc Dis. 1997;40:141-158.
2. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, Breithardt G. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003;362:1093-1099.
3. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108:788-794.
4. Indolfi C, Coppola C, Torella D, Arcucci O, Chiariello M. Gene therapy for restenosis after balloon angioplasty and stenting. Cardiol Rev. 1999;7:324-331.
5. Smith RC, Walsh K. Gene therapy for restenosis. Curr Cardiol Rep. 2000;2:13-23.
6. Bennett MR, O'Sullivan M. Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy. Pharmacol Ther. 2001;91:149-166.
7. Quarck R, Holvoet P. Restenosis and gene therapy. Expert Opin Biol Ther. 2001;1:79-91.
8. Rutanen J, Puhakka H, Yla-Herttuala S. Post-intervention vessel remodeling. Gene Ther. 2002;9:1487-1491.
9. Crook MF, Akyurek LM. Gene transfer strategies to inhibit neointima formation. Trends Cardiovasc Med. 2003;13:102-106.
10. Appleby CE, Kingston PA. Gene therapy for restenosis: what now, what next? Curr Gene Ther. 2004;4:153-182.
11. Morishita R. Perspective in progress of cardiovascular gene therapy. J Pharmacol Sci. 2004;95:1-8.
12. Kaneda Y, Morishita R, Dzau VJ. Prevention of restenosis by gene therapy. Ann N Y Acad Sci. 1997;811:299-308.
13. Ando H, Fukuda N, Kotani M, Yokoyama S, Kunimoto S, Matsumoto K, Saito S, Kanmatsuse K, Mugishima H. Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-β1 mRNA inhibits neointima formation in rat carotid artery after balloon injury. Eur J Pharmacol. 2004;483:207-214.
14. Mann MJ, Whittemore AD, Donaldson MC, Belkin M, Conte MS, Polak JF, Orav EJ, Ehsan A, Dell'Acqua G, Dzau VJ. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet. 1999;354:1493-1498.
15. 15: Morishita R, Gibbons GH, Horiuchi M, Ellison KE, Nakama M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci U S A. 1995;92:5855-5859.
16. Hashiya N, Aoki M, Tachibana K, Taniyama Y, Yamasaki K, Hiraoka K, Makino H, Yasufumi K, Ogihara T, Morishita R. Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model. Biochem Biophys Res Commun. 2004;317:508-514.
17. Ohtani K, Egashira K, Usui M, Ishibashi M, Hiasa KI, Zhao Q, Aoki M, Kaneda Y, Morishita R, Takeshita A. Inhibition of neointimal hyperplasia after balloon injury by cis-element "decoy" of early growth response gene-1 in hypercholesterolemic rabbits. Gene Ther. 2004;11:126-132.
18. Yoshimura S, Morishita R, Hayashi K, Yamamoto K, Nakagami H, Kaneda Y, Sakai N, Ogihara T. Inhibition of intimai hyperplasia after balloon injury in rat carotid artery model using cis-element "decoy" of nuclear factor-κB binding site as a novel molecular strategy. Gene Ther. 2001;8:1635-1642.
19. Tulis DA, Mnjoyan ZH, Schiesser RL, Shelat HS, Evans AJ, Zoldhelyi P, Fujise K. Adenoviral gene transfer of fortilin attenuates neointima formation through suppression of vascular smooth muscle cell proliferation and migration. Circulation. 2003;107:98-105.
20. Wang K, Kessler PD, Zhou Z, Penn MS, Forudi F, Zhou X, Tarakji K, Kibbe M, Kovesdi I, Brough DE, Topol EJ, Lincoff AM. Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model. Mol Ther. 2003;7:597-603.
21. Wu KK. Prostacyclin and nitric oxide-related gene transfer in preventing arterial thrombosis and restenosis. Agents Actions Suppl. 1997;48:107-123.
22. Tulis DA, Durante W, Liu X, Evans AJ, Peyton KJ, Schafer AI. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation. 2001;104:2710-2715.
23. Kong D, Melo LG, Mangi AA, Zhang L, Lopez-Ilasaca M, Perrella MA, Liew CC, Pratt RE, Dzau VJ. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation. 2004;109:1769-1775.
24. Shyue SK, Tsai MJ, Liou JY, Willerson JT, Wu KK. Selective augmentation of prostacyclin production by combined prostacyclin synthase and cyclooxygenase-1 gene transfer. Circulation. 2001;103:2090-2095.
25. Numaguchi Y, Okumura K, Harada M, Naruse K, Yamada M, Osanai H, Matsui H, Ito M, Murohara T. Catheter-based prostacyclin synthase gene transfer prevents in-stent restenosis in rabbit atheromatous arteries. Cardiovasc Res. 2004;61:177-185.
26. Zoldhelyi P, McNatt J, Xu XM, Loose-Mitchell D, Meidell RS, Clubb FJ Jr, Buja LM, Willerson JT, Wu KK. Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene. Circulation. 1996;93:10-17.
27. Zoldhelyi P, Chen ZQ, Shelat HS, McNatt JM, Willerson JT. Local gene transfer of tissue factor pathway inhibitor regulates intimai hyperplasia in atherosclerotic arteries. Proc Natl Acad Sci U S A. 2001;98:4078-4083.
28. Rade JJ, Schulick AH, Virmani R, Dichek DA. Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nat Med. 1996;2:293-298.
29. Griese DP, Achatz S, Batzlsperger CA, Strauch UG, Grumbeck B, Weil J, Riegger GA. Vascular gene delivery of anticoagulants by transplantation of retrovirally-transduced endothelial progenitor cells. Cardiovasc Res. 2003;58:469-477.
30. Akyurek LM, Nallamshetty S, Aoki K, San H, Yang ZY, Nabel GJ, Nabel EG. Coexpression of guanylate kinase with thymidine kinase enhances prodrug cell killing in vitro and suppresses vascular smooth muscle cell proliferation in vivo. Mol Ther. 2001;3:779-786.
31. Schwartz SM. The intima: a new soil. Circ Res. 1999;85:877-879.
32. Willerson JT, Yao SK, McNatt J, Benedict CR, Anderson HV, Golino P, Murphree SS, Buja LM. Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Proc Natl Acad Sci U S A. 1991;88:10624-10628.
33. Kadokami T, Shimokawa H, Fukumoto Y, Ito A, Takayanagi T, Egashira K, Takeshita A. Coronary artery spasm does not depend on the intracellular calcium store but is substantially mediated by the protein kinase C-mediated pathway in a swine model with interleukin-1β in vivo. Circulation. 1996;94:190-196.
34. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, Wilcox JN. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation. 1996;93:2178-2187.
35. Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A. Adventitial remodeling after coronary arterial injury. Circulation. 1996;93:340-348.
36. Aliev G, Burnstock G. Watanabe rabbits with heritable hypercholesterolaemia: a model of atherosclerosis. Histol Histopathol. 1998;13:797-817.
37. Buja LM, Clubb FJ Jr, Bilheimer DW, Willerson JT. Pathobiology of human familial hypercholesterolaemia and a related animal model, the Watanabe heritable hyperlipidaemic rabbit. Eur Heart J. 1990;11:41-52.
38. Kimura T, Kaburagi S, Tamura T, Yokoi H, Nakagawa Y, Hamasaki N, Nosaka H, Nobuyoshi M, Mintz GS, Popma JJ, Leon MB. Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Circulation. 1997;96:475-483.
39. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996;94:35-43.
40. Gruchala M, Bhardwaj S, Pajusola K, Roy H, Rissanen TT, Kokina I, Kholova I, Markkanen JE, Rutanen J, Heikura T, Alitalo K, Bueler H, Yla-Herttuala S. Gene transfer into rabbit arteries with adeno-associated virus and adenovirus vectors. J Gene Med. 2004;6:545-554.
41. Cho A, Mitchell L, Koopmans D, Langille BL. Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits. Circ Res. 1997;81:328-337.
42. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemsa, and hypertension. J Clin Invest. 1993;92:652-662.
43. Lee PC, Gibbons GH, Dzau VJ. Cellular and molecular mechanisms of coronary artery restenosis. Coron Artery Dis. 1993;4:254-259.
44. Johnson MM, Swan DD, Surette ME, Stegner J, Chilton T, Fonteh AN, Chilton FH. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr. 1997;127:1435-1444.
45. Zurier RB, Rossetti RG, Jacobson EW, DeMarco DM, Liu NY, Temming JE, White BM, Laposata M. γ-Linolenic acid treatment of rheumatoid arthritis: a randomized, placebo-controlled trial. Arthritis Rheum. 1996;39:1808-1817.
46. Cameron NE, Cotter MA. Comparison of the effects of ascorbyl γ-linolenic acid and γ-linolenic acid in the correction of neurovascular deficits in diabetic rats. Diabetologia. 1996;39:1047-1054.
47. Kloeze J. Relationship between chemical structure and platelet aggregation activity of prostaglandins. Biochem Biophys Acta. 1969;187:285-292.
48. Willis AL, Stone JK, Hart M, Gibson V, Marples P, Botfield E, Comai K, Kuhn DC. Dietary fatty acids, prostaglandins, endoperoxides and the prevention of thrombosis. In: Silver MJ, Smith JB, Kocsis JJ, eds. Prostaglandins in Hematology. New York, NY: Spectrum Publications; 1977:371-410.
49. Palasis M, Luo Z, Barry JJ, Walsh K. Analysis of adenoviral transport mechanisms in the vessel wall and optimization of gene transfer using local delivery catheters. Hum Gene Ther. 2000;11:237-246.